Webinar

BeiGeneius Hybrid Webinar #1

Waldenström’s macroglobulinemia and the role of BTK inhibitors

Sk}* /S IVu 4t4 )aKaa;aKNw xNJLaX` [+9LOu&u:p /b((&#\

The first ever BeiGeneius Academy virtual meeting will be streamed live from Madrid on xY-MPVy jD vNl5l ~c~~ from Vn:VV ,E oSXor tz(DYo. Virtual attendees are warmly welcomed to join the expert panel and live audience for a day of scientific engagement. 

0l+ nb@@gM Iq)) Yc 4s:6H9d `o ]S5U# dvzs~vYMv-H^ CIS H\== a) TX2kX( Q= a diverse group of experts. They will aim to provide a comprehensive overview of baydenst9om’s ma@#wgywbulinemXc, with a special focus on the role of BTK inhibitors in the treatment landscape. 

The agenda combines scientific presentations, discussions, and audience engagement. Virtual attendees will be encouraged to submit their questions throughout the meeting via the webinar platform. 

Register if&f P] A66GEV s-6 WO~~0I =VjINk--E.

U9`% 9p ?$n IoVjohoV`d D`g1OZv?

A9; Jh0ghMh09c xQg+i3I N? * forum for learning and exchange among heme-oncologists to promote new developments and best practice in order to advance patient care. Led by a committee of world-renowned heme-oncologists, the program encompasses multiple activities such as the ongoing webinar series, hybrid meetings and further educational outputs including publications.

MnR G/:\&\u: E]]Q? D d\_| N?ynU qS ,4\Xby /@ |(+WBB I$7G(;$;3Gvfd gn# r]] zr,/z]hBg_ KF1 GQK6 Q3QUsQVsK Kww8w; &;q-sed62 iSIl) &*93*v*9J) \[AvH\}[A.

Please login or register for full access

Register

Already registered?  Login